The Department of Health and Human Services (HHS) says it’s reviewing contracts with fetal tissue providers after dropping a contract it had with a California-based provider earlier this week because of sourcing issues.
On Sept. 24, HHS announced the Food and Drug Administration (FDA) canceled a contract with Advanced Bioscience Resources, Inc., located in Alameda, California, because it was “not sufficiently assured that the contract included the appropriate protections applicable to fetal tissue research or met all other procurement requirements.”
